Loading organizations...
Puma Venture Capital is an investment firm focused on the digital surgery ecosystem, supporting companies developing technological solutions for surgical procedures and patient care. Its strategy leverages surgeon venture partners, providing clinical perspectives and industry expertise to guide specialized investment decisions.
Co-founded in 2023 by Amit Hazan and Dr. Vipul Patel in Del Mar, California, the firm arose from the insight that combining investment acumen with deep clinical expertise would advance digital surgery. Hazan brings a Goldman Sachs investment background, while Dr. Patel contributes a critical surgeon’s perspective, foundational to their model.
The firm partners with entrepreneurs creating solutions for surgical precision, automation, and data-driven improvements. Puma Venture Capital’s mission is to catalyze surgical practice transformation by offering strategic capital and expert guidance, ultimately enhancing efficiency, safety, and accessibility globally.
Puma Venture Capital has 3 tracked investments across 3 companies. The latest tracked deal is $70.0M Series B in Vitestro in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 10, 2026 | Vitestro | $70.0M Series B | — | Fred Moll, M.D, EIC Fund, Intervest, Megann Vaughn Watters, Mayo Clinic, McPike Global Family Office, Nybc Ventures, Pggm, ROM Utrecht Region, Sonder Capital, Sutter Health |
| Nov 4, 2025 | Sovato | $41.0M Series B | Michael Gross, Beringea, Michael Gross | GS Ventures, Intuitive Ventures, Laerdal Medical, Polaris Partners, Teladoc Health, Vitalize Venture Group, Laerdal, Polaris Partners |
| Jul 25, 2024 | Navigantis | $12.0M Series A | Puma Venture Capital | — |
